Xu-Dong Hou

发表

Discovery and Characterization of the Naturally Occurring Inhibitors Against Human Pancreatic Lipase in Ampelopsis grossedentata

Guangbo Ge, Liangliang Zhu, Xiaodong Qin, 2022, Frontiers in Nutrition.

Ethnopharmacology, chemodiversity, and bioactivity of Cephalotaxus medicinal plants.

P. Xiao, Guangbo Ge, D. Hao, 2021, Chinese journal of natural medicines.

Beta-Glucuronidase Inhibition by Constituents of Mulberry Bark

Yuqi He, Qi Zhou, Yun-feng Cao, 2021, Planta Medica.

Discovery of human pancreatic lipase inhibitors from root of Rhodiola crenulata via integrating bioactivity-guided fractionation, chemical profiling and biochemical assay

Guangbo Ge, Xiaodong Qin, Xu-Dong Hou, 2022, Journal of pharmaceutical analysis.

Discovery and characterization of naturally occurring chalcones as potent inhibitors of bile salt hydrolases

Chun Xing Li, Guangbo Ge, J. Hou, 2022, Acta Materia Medica.

Design, synthesis and biological evaluation of novel chalcone-like compounds as potent and reversible pancreatic lipase inhibitors.

Nan Zhang, P. Liu, Guangbo Ge, 2020, Bioorganic & medicinal chemistry.

Natural constituents from Cortex Mori Radicis as new pancreatic lipase inhibitors.

Guangbo Ge, Yun-feng Cao, Z. Dai, 2018, Bioorganic chemistry.

Biflavones from Ginkgo biloba as novel pancreatic lipase inhibitors: Inhibition potentials and mechanism.

Guangbo Ge, Huiliang Li, Z. Dai, 2018, International journal of biological macromolecules.

Pancreatic lipase inhibitory constituents from Fructus Psoraleae.

Guangbo Ge, Qi Zhou, Yun-feng Cao, 2020, Chinese journal of natural medicines.

Inhibition of pancreatic lipase by the constituents in St. John's Wort: In vitro and in silico investigations.

Guangbo Ge, Ling Yang, Qi Zhou, 2019, International journal of biological macromolecules.

Rational design and development of a novel and highly specific near-infrared fluorogenic substrate for sensing and imaging of human pancreatic lipase in living systems

Zhenhao Tian, Xu-Dong Hou, J. Hou, 2021 .

Human carboxylesterase 1A plays a predominant role in hydrolysis of the anti-dyslipidemia agent fenofibrate in humans.

Hong-xin Li, Guangbo Ge, Xu-Dong Hou, 2023, Drug metabolism and disposition: the biological fate of chemicals.

Drug Metabolism and Disposition: DMD-AR-2023-001365R1 Human carboxylesterase 1A plays a predominant role in hydrolysis of the anti-dyslipidemia agent fenofibrate in humans

Hong-xin Li, Guangbo Ge, Xu-Dong Hou, 2023 .

Discovery of baicalein derivatives as novel inhibitors against human pancreatic lipase: Structure-activity relationships and inhibitory mechanisms.

Xu-Dong Hou, Yufan Fan, Guanghao Zhu, 2024, International journal of biological macromolecules.

The potential of natural sources for pancreatic lipase inhibitors: a solution of the obesity crisis?

Guangbo Ge, Xiaodong Qin, Xu-Dong Hou, 2022, Expert opinion on drug discovery.